Pipeline

 

Umoja Biopharma is committed to developing innovative therapies through rigorous clinical research that address critical unmet needs. Currently, we do not offer access to our investigational therapies outside of clinical trials. We believe that participation in clinical trials is the most appropriate and equitable pathway for patients to access our investigational therapies until the safety and tolerability of each has been established and evaluated by regulatory authorities.

 

For more information about our ongoing studies, please visit clinicaltrials.gov. Search “Umoja” to find our clinical trials that may be recruiting. If you are a healthcare professional and would like more information on our investigational therapies, please send an inquiry to info@umoja-biopharma.com.